Universe Pharmaceuticals (UPC) Competitors $0.51 -0.02 (-3.01%) As of 01/21/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrends UPC vs. ARTL, ALBT, SNOA, LIPO, NBY, SBFM, ATXI, HEPA, KTTA, and PTPIShould you be buying Universe Pharmaceuticals stock or one of its competitors? The main competitors of Universe Pharmaceuticals include Artelo Biosciences (ARTL), Avalon GloboCare (ALBT), Sonoma Pharmaceuticals (SNOA), Lipella Pharmaceuticals (LIPO), NovaBay Pharmaceuticals (NBY), Sunshine Biopharma (SBFM), Avenue Therapeutics (ATXI), Hepion Pharmaceuticals (HEPA), Pasithea Therapeutics (KTTA), and Petros Pharmaceuticals (PTPI). These companies are all part of the "pharmaceutical products" industry. Universe Pharmaceuticals vs. Artelo Biosciences Avalon GloboCare Sonoma Pharmaceuticals Lipella Pharmaceuticals NovaBay Pharmaceuticals Sunshine Biopharma Avenue Therapeutics Hepion Pharmaceuticals Pasithea Therapeutics Petros Pharmaceuticals Universe Pharmaceuticals (NYSE:UPC) and Artelo Biosciences (NASDAQ:ARTL) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, community ranking, earnings, dividends, profitability, analyst recommendations, valuation and risk. Does the MarketBeat Community prefer UPC or ARTL? Artelo Biosciences received 46 more outperform votes than Universe Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformUniverse PharmaceuticalsN/AN/AArtelo BiosciencesOutperform Votes4676.67% Underperform Votes1423.33% Do analysts recommend UPC or ARTL? Artelo Biosciences has a consensus price target of $5.50, suggesting a potential upside of 356.81%. Given Artelo Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Artelo Biosciences is more favorable than Universe Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Universe Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Artelo Biosciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50 Which has better earnings & valuation, UPC or ARTL? Universe Pharmaceuticals has higher revenue and earnings than Artelo Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUniverse Pharmaceuticals$32.31M0.03-$6.16MN/AN/AArtelo BiosciencesN/AN/A-$9.29M-$2.87-0.42 Does the media favor UPC or ARTL? In the previous week, Artelo Biosciences had 1 more articles in the media than Universe Pharmaceuticals. MarketBeat recorded 1 mentions for Artelo Biosciences and 0 mentions for Universe Pharmaceuticals. Universe Pharmaceuticals' average media sentiment score of 0.00 equaled Artelo Biosciences'average media sentiment score. Company Overall Sentiment Universe Pharmaceuticals Neutral Artelo Biosciences Neutral Which has more volatility and risk, UPC or ARTL? Universe Pharmaceuticals has a beta of 1.46, suggesting that its stock price is 46% more volatile than the S&P 500. Comparatively, Artelo Biosciences has a beta of 1.25, suggesting that its stock price is 25% more volatile than the S&P 500. Do insiders & institutionals believe in UPC or ARTL? 0.2% of Universe Pharmaceuticals shares are owned by institutional investors. Comparatively, 0.9% of Artelo Biosciences shares are owned by institutional investors. 57.4% of Universe Pharmaceuticals shares are owned by company insiders. Comparatively, 0.8% of Artelo Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is UPC or ARTL more profitable? Universe Pharmaceuticals' return on equity of 0.00% beat Artelo Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Universe PharmaceuticalsN/A N/A N/A Artelo Biosciences N/A -104.59%-94.06% SummaryArtelo Biosciences beats Universe Pharmaceuticals on 7 of the 13 factors compared between the two stocks. Get Universe Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for UPC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPC vs. The Competition Export to ExcelMetricUniverse PharmaceuticalsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$871,000.00$6.57B$5.39B$20.02BDividend YieldN/A2.96%5.37%3.61%P/E RatioN/A10.0188.8341.78Price / Sales0.03315.791,280.4817.50Price / CashN/A22.6336.6017.54Price / Book0.005.084.965.86Net Income-$6.16M$154.90M$117.89M$1.01B7 Day Performance-3.38%1.33%1.67%2.11%1 Month Performance-20.52%1.52%3.62%6.05%1 Year Performance-98.42%4.60%26.15%19.05% Universe Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPCUniverse PharmaceuticalsN/A$0.51-3.0%N/A-98.5%$871,000.00$32.31M0.00220ARTLArtelo Biosciences2.9906 of 5 stars$1.12-3.4%$5.50+391.1%-15.8%$3.62MN/A-0.395Positive NewsALBTAvalon GloboCare0.4507 of 5 stars$3.26-5.7%N/A-41.5%$3.60M$1.31M-0.165Positive NewsSNOASonoma Pharmaceuticals0.9049 of 5 stars$2.66+2.3%N/A+1,494.5%$3.56M$13.55M-0.53180Positive NewsLIPOLipella Pharmaceuticals2.4729 of 5 stars$2.93+1.0%$16.00+446.1%-62.8%$3.54M$483,533.00-0.694Negative NewsNBYNovaBay Pharmaceuticals0.8201 of 5 stars$0.72+3.1%$0.85+18.3%-86.9%$3.53M$13.84M-0.0130Analyst ForecastNews CoverageSBFMSunshine Biopharma2.1463 of 5 stars$2.85-2.7%$15.00+426.3%-87.5%$3.49M$32.96M-0.023News CoverageATXIAvenue Therapeutics2.9438 of 5 stars$1.83+0.8%N/A-82.4%$3.47MN/A0.094Positive NewsHEPAHepion Pharmaceuticals1.0177 of 5 stars$0.50-2.4%N/A-84.9%$3.47MN/A-0.1120Positive NewsKTTAPasithea Therapeutics0.7895 of 5 stars$2.68+4.7%N/A-64.5%$3.39M$20,000.000.003PTPIPetros Pharmaceuticals0.0934 of 5 stars$0.34-10.2%N/A-73.6%$3.38M$4.02M-0.0720 Related Companies and Tools Related Companies ARTL Alternatives ALBT Alternatives SNOA Alternatives LIPO Alternatives NBY Alternatives SBFM Alternatives ATXI Alternatives HEPA Alternatives KTTA Alternatives PTPI Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:UPC) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universe Pharmaceuticals INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Universe Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UPC Stock Alerts